AbstractObjectiveTo investigate the relationship in malignant-neoplasm patients of hypercoagulability between syndromes differentiated with the theory of abnormal hilit in traditional Uyghur medicine (TUM).MethodsA total of 248 patients with malignant tumors were enrolled. Based on the theory of TUM they were divided into two groups: abnormal Savda and abnormal Non-Savda (including abnormal Khan, abnormal Sepra and abnormal Belghem types); fifty healthy volunteers were selected as controls. Platelet (PLT), prothrombin time (PT), plasma fibrinogen (FIB), thrombin time (TT), activated partial thromboplastin time (aPTT) and D-Dimer (D-D) were measured in both groups.ResultsCompared with the control and abnormal Non-Savda groups, in the abnorma...
AbstractPatients with cancer have prothrombotic and hypercoagulable state, which leads to higher ris...
Different coagulation and fibrinolysis parameters were investigated in 149 patients with metastatic ...
Introduction: A detailed evaluation of the malignancy-associated coagulopathy (MAC) in surgical pati...
A hypercoagulable or prothrombotic state of malig-nancy occurs due to the ability of tumor cells to ...
thrombophelebitis in patients with cancer. Thrombo-sis may be a presenting feature of occult maligna...
Hemostatic complications are one of the leading causes of mortality in cancer patients. In the prese...
(1) Objective: hypercoagulability in patients with malignant neoplasm were evaluated to examine the ...
Background: Though the actual symptoms of any haemostatic abnormalities in patients of solid maligna...
Introduction. It is fully recognized that cancer patients are at significant risk of developing thro...
International audienceBackgroundIn breast cancer patients routine thromboprophylaxis is not recommen...
Background and objective The prethrombotic state can be observed in advanced lung cancer patients. T...
Brain tumors have the highest percentage of thrombosis compared to other types of malignancies. Hype...
Some haemostatic parameters such as relative plasma viscosity (RPV), platelet count (PC) Prothrombin...
<div><p>Patients with malignancy are at higher risk of thrombotic complications due to the hypercoag...
Summary: Coagulation and fibrinolysis activation have been investigated in fifty-eight women with re...
AbstractPatients with cancer have prothrombotic and hypercoagulable state, which leads to higher ris...
Different coagulation and fibrinolysis parameters were investigated in 149 patients with metastatic ...
Introduction: A detailed evaluation of the malignancy-associated coagulopathy (MAC) in surgical pati...
A hypercoagulable or prothrombotic state of malig-nancy occurs due to the ability of tumor cells to ...
thrombophelebitis in patients with cancer. Thrombo-sis may be a presenting feature of occult maligna...
Hemostatic complications are one of the leading causes of mortality in cancer patients. In the prese...
(1) Objective: hypercoagulability in patients with malignant neoplasm were evaluated to examine the ...
Background: Though the actual symptoms of any haemostatic abnormalities in patients of solid maligna...
Introduction. It is fully recognized that cancer patients are at significant risk of developing thro...
International audienceBackgroundIn breast cancer patients routine thromboprophylaxis is not recommen...
Background and objective The prethrombotic state can be observed in advanced lung cancer patients. T...
Brain tumors have the highest percentage of thrombosis compared to other types of malignancies. Hype...
Some haemostatic parameters such as relative plasma viscosity (RPV), platelet count (PC) Prothrombin...
<div><p>Patients with malignancy are at higher risk of thrombotic complications due to the hypercoag...
Summary: Coagulation and fibrinolysis activation have been investigated in fifty-eight women with re...
AbstractPatients with cancer have prothrombotic and hypercoagulable state, which leads to higher ris...
Different coagulation and fibrinolysis parameters were investigated in 149 patients with metastatic ...
Introduction: A detailed evaluation of the malignancy-associated coagulopathy (MAC) in surgical pati...